The MD-6000 Bladder Scanner is a non-invasive diagnostic tool that measures the amount of urine in the bladder or used to determine how much urine remains in the bladder after urination as a way to ...
The FDA has approved Pfizer and Merck KGaA’s immunotherapy Bavencio (avelumab) as a first line maintenance therapy in bladder cancer, setting up a rivalry with alternatives from Roche and AstraZeneca.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results